<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02964416</url>
  </required_header>
  <id_info>
    <org_study_id>2954-Ane-ERC-14</org_study_id>
    <nct_id>NCT02964416</nct_id>
  </id_info>
  <brief_title>Single Dose Tramadol Effect on Extubation Response and Quality of Emergence Post-supratentorial Intracranial Surgery</brief_title>
  <official_title>Effect of Single Dose of Tramadol on Extubation Response and Quality of Emergence(Cough and Nausea Vomiting) Following Supratentorial Intracranial Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aga Khan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aga Khan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several modalities have been studied to prevent coughing during emergence, including&#xD;
      extubation in a deep plane of anesthesia but have proved to be unreliable. So far, no&#xD;
      reliable method is recommended as standard of care. The advantages of administering tramadol&#xD;
      includes a long duration of action, rapid recovery, limited depression of respiratory&#xD;
      function and no effect on platelet makes it a safe medication to use for neurosurgical&#xD;
      patients after craniotomy. The primary objective of the study is to observe the effect of&#xD;
      single dose of tramadol (1mg/kg) administered 45 minutes before extubation on hemodynamic&#xD;
      response (measurement of B.P and H.R) during extubation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Extubation after intracranial tumor surgery is desirable in order to make an early diagnosis&#xD;
      of intracranial complications. Extubation however, may be associated with haemodynamic and&#xD;
      metabolic changes e.g. agitation, increased oxygen consumption, catecholamine secretion,&#xD;
      hypercapnia and systemic hypertension.&#xD;
&#xD;
      These changes cause cerebral hyperemia, intracranial hypertension leading to cerebral oedema&#xD;
      or haemorrhage, thus it is important to have smooth extubation with minimal haemodynamic and&#xD;
      metabolic effects.&#xD;
&#xD;
      Incidence of coughing on emergence from general anesthesia ranges from 38% to 96%. This may&#xD;
      also result in postoperative intracranial hemorrhage, intracranial hypertension, cerebral&#xD;
      edema or intraocular hypertension.This can be detrimental in neurosurgery.&#xD;
&#xD;
      Several modalities have been studied to prevent coughing during emergence, including&#xD;
      extubation in a deep plane of anesthesia but have proved to be unreliable. So far, no&#xD;
      reliable method is recommended as standard of care.&#xD;
&#xD;
      Tramadol, a synthetic opioid of the aminocyclohexanes group, is a centrally acting opioid&#xD;
      analgesic that is used to treat moderate-to-severe pain and has an inhibitory effect on M1&#xD;
      and M3 muscarinic receptors. It also reduces the incidence of cough and improves extubation&#xD;
      quality, and provides more stable haemodynamics during emergence. It neither causes&#xD;
      respiratory depression, nor affects intracranial pressure (ICP) and cerebral perfusion&#xD;
      pressure (CPP). Other potential advantage of administering tramadol includes a long duration&#xD;
      of action, rapid recovery, limited depression of respiratory function and no effect on&#xD;
      platelets thus making it a safe medication to use for neurosurgical patients after&#xD;
      craniotomy. The onset of effect following a single dose is 3 to 5 minutes with peak effect at&#xD;
      45 minutes.&#xD;
&#xD;
      Aim of doing this study is to observe the effect of a single dose of tramadol on quality of&#xD;
      tracheal extubation as judged by incidence of coughing and haemodynamic changes at emergence&#xD;
      from anesthesia.&#xD;
&#xD;
      OBJECTIVE:&#xD;
&#xD;
      Primary Objective: To observe the effect of single dose of tramadol (1mg/kg) administered 45&#xD;
      minutes before extubation on haemodynamic response (measurement of B.P and H.R) during&#xD;
      extubation.&#xD;
&#xD;
      Secondary Objective: To measure the quality of emergence from general anaesthesia by&#xD;
      measuring the frequency of cough, laryngospasm and episodes of desaturation.&#xD;
&#xD;
      OPERATIONAL DEFINITION:&#xD;
&#xD;
      Emergence Period: This will be defined as the time from the recovery of spontaneous breathing&#xD;
      after giving reversal to tracheal extubation.&#xD;
&#xD;
      Quality of emergence: Good quality emergence will be defined as extubation not associated&#xD;
      with coughing, bucking, tachycardia, hypertension, laryngospasm or bronchospasm.&#xD;
&#xD;
      Tachycardia and hypertension: Rise in heart rate and blood pressure more than 20% from&#xD;
      baseline value.&#xD;
&#xD;
      Extubation response: Physiological response related to blood pressure and heart rate during&#xD;
      extubation of trachea is called extubation response,&#xD;
&#xD;
      HYPOTHESIS:&#xD;
&#xD;
      Tramadol obtunds haemodynamic and cough response to extubation and thus results in good&#xD;
      quality emergence after supratentorial craniotomy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2016</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">March 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Haemodynamic Parameters at the Time of Emergence and Postextubation</measure>
    <time_frame>Systolic BP from the time of extubation till 6 hours post operatively</time_frame>
    <description>Systolic blood pressure will be recorded at 1 minute before giving the reversal (glycopyrolate and neostigmine) and then 1,2,5,10,20,30 minutes ,1,2,4 and 6 hours after extubation. If values of blood pressure rise more than 20% from baseline values injection Metoprolol 1mg (beta blocker) bolus will be used and titrated according to response. The study will end at 6 hours post extubation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Haemodynamic Parameters at the Time of Emergence and Postextubation</measure>
    <time_frame>HR from the time of extubation till 6 hours post operatively</time_frame>
    <description>Heart rate will be recorded at 1 minute before giving the reversal (glycopyrolate and neostigmine) and then 1,2,5,10,20,30 minutes ,1,2,4 and 6 hours after extubation. If haemodynamic values of heart rate rise more than 20% from baseline values injection Metoprolol 1mg (beta blocker) bolus will be used and titrated according to response. The study will end at 6 hours post extubation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Haemodynamic Parameters at the Time of Emergence and Postextubation</measure>
    <time_frame>Diastolic BP from the time of extubation till 6 hours post operatively</time_frame>
    <description>Diastolic blood pressure will be recorded at 1 minute before giving the reversal (glycopyrolate and neostigmine) and then 1,2,5,10,20,30 minutes ,1,2,4 and 6 hours after extubation. If values of blood pressure rise more than 20% from baseline values injection Metoprolol 1mg (beta blocker) bolus will be used and titrated according to response. The study will end at 6 hours post extubation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure the Quality of Emergence From General Anaesthesia by Measuring the Frequency of Cough on Cough Scale.</measure>
    <time_frame>Cough at the time of emergence</time_frame>
    <description>Cough will be described on following scale 5 = No coughing or straining, 4 = Very smooth minimal coughing, 3 = Moderate coughing, 2 = Marked coughing or straining,&#xD;
1 = Poor extubation&#xD;
Cough will be recorded on the above mentioned scale by resident/consultant at following time intervals of emergence&#xD;
At resumption of spontaneous breathing,&#xD;
Ability to respond to verbal commands&#xD;
At cuff deflation&#xD;
At extubation&#xD;
2 minutes after extubation. It will be noted if it occurs during emergence at the above mentioned time intervals. Absence of it will be considered as smooth emergence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure the Quality of Emergence From General Anaesthesia by Measuring the Frequency of Laryngospasm and Bronchospasm.</measure>
    <time_frame>at the time of extubation till 6 hours postoperatively</time_frame>
    <description>If there is any episode of bronchospasm or laryngospasm, it will be noted if it occured during emergence and for 6 hours post operatively. Absence of it will be considered as smooth emergence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure the Quality of Emergence From General Anaesthesia by Measuring Sedation Score</measure>
    <time_frame>at the time of extubation till 6 hours postoperatively</time_frame>
    <description>If there is any episode of sedation it will be noted if it occurs during emergence and for 6 hours post operatively. Absence of it will be considered as smooth emergence.&#xD;
sedation score will be used as 0= no sedation, 1= mildly sedated (eye opening on verbal commands), 2= moderately sedated ( awakens on giving pain), 3= deeply sedated ( not waking up even on pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Tramadol on Quality of Emergence Measured by Extubation Response Through Monitoring PONV</measure>
    <time_frame>at Recovery Room , 2, 4 and 6 hours postoperatively</time_frame>
    <description>Post operative nausea vomiting will be recorded at RR, 2, 4 and 6 hours postoperatively. If there is any episode of PONV it will be noted. Absence of it will be considered as smooth emergence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Tramadol on Quality of Emergence Measured by Extubation Response Through Monitoring Convulsions</measure>
    <time_frame>at Recovery Room, 2, 4 and 6 hours postoperatively</time_frame>
    <description>Convulsions will be recorded at Recovery Room, 2, 4 and 6 hours postoperatively.If there is any episode of convulsion, it will be noted. Absence of it will be considered as smooth emergence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Tramadol on Quality of Emergence Measured by Extubation Response Through Monitoring GCS</measure>
    <time_frame>at Recovery Room, 2, 4 and 6 hours postoperatively</time_frame>
    <description>Post operative Glasgow Coma Scale (GCS) will be recorded at Recovery Room, 2, 4 and 6 hours postoperatively. If there is any deterioration in GCS less than 8/15, Patients will be intubated.&#xD;
GCS categories &lt;8 Low GCS 9-12 Intermediate GCS 13-15 Full GCS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Tramadol on Quality of Emergence Measured by Extubation Response Through Mointoring Requirement of Analgesia</measure>
    <time_frame>At Recovery room, 2, 4 and 6 hours postoperatively</time_frame>
    <description>Requirement of analgesia will be recorded at recovery room, 2, 4 and 6 hours postoperatively. If there is any need of analgesic, it will be noted and will be considered as one of the determinants of poor quality of emergence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure the Quality of Emergence From General Anaesthesia by Measuring the Frequency of Episodes of Denaturation</measure>
    <time_frame>at the time of extubation</time_frame>
    <description>If there is any episodes of denaturation (Oxygen saturation &lt;92%), it will be noted it it is occurring during emergence.&#xD;
Absence of it will be considered as smooth emergence</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Brain Neoplasm</condition>
  <arm_group>
    <arm_group_label>Tramadol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg or (1ml/10kg) via intravenous route, once, at the time of dura closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Injection Tramadol</intervention_name>
    <arm_group_label>Tramadol</arm_group_label>
    <other_name>Tramal</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>0.9% Normal saline in 10 ml syringe</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with craniotomy for supratentorial tumors under general anesthesia&#xD;
&#xD;
          -  American Society of Anaesthesiologists (ASA) 2 and stable ASA 3 patients&#xD;
&#xD;
          -  Elective surgery&#xD;
&#xD;
          -  Patients with Glasgow Coma Scale (GCS) 15/15&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a history of allergy or hypersensitivity to tramadol.&#xD;
&#xD;
          -  History of epilepsy or convulsions due to any reason.&#xD;
&#xD;
          -  Chronic usage of analgesic drugs.&#xD;
&#xD;
          -  Patients using monoamine oxidase inhibitors.&#xD;
&#xD;
          -  Patients with clinical signs of raised ICP.&#xD;
&#xD;
          -  Obesity (women with a body mass index &gt;35 kg/m2 or men with a body mass index &gt;42&#xD;
             kg/m2)&#xD;
&#xD;
          -  Language barrier.&#xD;
&#xD;
          -  Patients taking B-blockers or Ca channel blockers.&#xD;
&#xD;
          -  Patients above 65 years of age ( Physiology difference)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Asma A Salam, MCPS, FCPS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aga Khan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aga Khan University</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <zip>74800</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <reference>
    <citation>Mikawa K, Nishina K, Maekawa N, Obara H. Attenuation of cardiovascular responses to tracheal extubation: verapamil versus diltiazem. Anesth Analg. 1996 Jun;82(6):1205-10.</citation>
    <PMID>8638792</PMID>
  </reference>
  <reference>
    <citation>Lin BF, Ju DT, Cherng CH, Hung NK, Yeh CC, Chan SM, Wu CT. Comparison between intraoperative fentanyl and tramadol to improve quality of emergence. J Neurosurg Anesthesiol. 2012 Apr;24(2):127-32. doi: 10.1097/ANA.0b013e31823c4a24.</citation>
    <PMID>22089326</PMID>
  </reference>
  <reference>
    <citation>Valley RD, Ramza JT, Calhoun P, Freid EB, Bailey AG, Kopp VJ, Georges LS. Tracheal extubation of deeply anesthetized pediatric patients: a comparison of isoflurane and sevoflurane. Anesth Analg. 1999 Apr;88(4):742-5.</citation>
    <PMID>10195515</PMID>
  </reference>
  <reference>
    <citation>Neelakanta G, Miller J. Minimum alveolar concentration of isoflurane for tracheal extubation in deeply anesthetized children. Anesthesiology. 1994 Apr;80(4):811-3.</citation>
    <PMID>8024135</PMID>
  </reference>
  <reference>
    <citation>Ferber J, Juniewicz H, Głogowska E, Wroński J, Abraszko R, Mierzwa J. Tramadol for postoperative analgesia in intracranial surgery. Its effect on ICP and CPP. Neurol Neurochir Pol. 2000;34(6 Suppl):70-9.</citation>
    <PMID>11452859</PMID>
  </reference>
  <reference>
    <citation>Sudheer PS, Logan SW, Terblanche C, Ateleanu B, Hall JE. Comparison of the analgesic efficacy and respiratory effects of morphine, tramadol and codeine after craniotomy. Anaesthesia. 2007 Jun;62(6):555-60.</citation>
    <PMID>17506732</PMID>
  </reference>
  <reference>
    <citation>Rahimi SY, Alleyne CH, Vernier E, Witcher MR, Vender JR. Postoperative pain management with tramadol after craniotomy: evaluation and cost analysis. J Neurosurg. 2010 Feb;112(2):268-72. doi: 10.3171/2008.9.17689.</citation>
    <PMID>19630495</PMID>
  </reference>
  <reference>
    <citation>Lintz W, Beier H, Gerloff J. Bioavailability of tramadol after i.m. injection in comparison to i.v. infusion. Int J Clin Pharmacol Ther. 1999 Apr;37(4):175-83.</citation>
    <PMID>10235420</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 19, 2016</study_first_submitted>
  <study_first_submitted_qc>November 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2016</study_first_posted>
  <results_first_submitted>July 28, 2019</results_first_submitted>
  <results_first_submitted_qc>July 21, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 4, 2020</results_first_posted>
  <last_update_submitted>July 21, 2020</last_update_submitted>
  <last_update_submitted_qc>July 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aga Khan University</investigator_affiliation>
    <investigator_full_name>Asma Abdus Salam</investigator_full_name>
    <investigator_title>Senior Instructor</investigator_title>
  </responsible_party>
  <keyword>supratentorial craniotomy</keyword>
  <keyword>extubation response</keyword>
  <keyword>emergence</keyword>
  <keyword>tramadol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 5, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/16/NCT02964416/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Over a period of two years, 2016 and 2017&#xD;
Patients were recruited in the study during the preoperative anesthesia evaluation either at the preoperative clinic or from the ward after admission.</recruitment_details>
      <pre_assignment_details>A total of 80 patients were enrolled and selected to randomize. 39 patients in Tramadol group and 41 patients in placebo group.79 patients completed the study as one patient in tramadol group dropped out due to change/ modification in his surgical procedure.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Tramadol</title>
          <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg or (1ml/10kg) via intravenous route, once, at the time of dura closure&#xD;
Injection Tramadol</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure&#xD;
placebo: 0.9% Normal saline in 10 ml syringe</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Tramadol</title>
          <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg or (1ml/10kg) via intravenous route, once, at the time of dura closure</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="38"/>
            <count group_id="B2" value="41"/>
            <count group_id="B3" value="79"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.42" spread="13.2"/>
                    <measurement group_id="B2" value="45.9" spread="15.9"/>
                    <measurement group_id="B3" value="44.7" spread="14.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="79"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="00"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Pakistan</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.2" spread="4.80"/>
                    <measurement group_id="B2" value="27.1" spread="4.88"/>
                    <measurement group_id="B3" value="26.7" spread="4.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Haemodynamic Parameters at the Time of Emergence and Postextubation</title>
        <description>Systolic blood pressure will be recorded at 1 minute before giving the reversal (glycopyrolate and neostigmine) and then 1,2,5,10,20,30 minutes ,1,2,4 and 6 hours after extubation. If values of blood pressure rise more than 20% from baseline values injection Metoprolol 1mg (beta blocker) bolus will be used and titrated according to response. The study will end at 6 hours post extubation.</description>
        <time_frame>Systolic BP from the time of extubation till 6 hours post operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tramadol</title>
            <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg or (1ml/10kg) via intravenous route, once, at the time of dura closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
          </group>
        </group_list>
        <measure>
          <title>Haemodynamic Parameters at the Time of Emergence and Postextubation</title>
          <description>Systolic blood pressure will be recorded at 1 minute before giving the reversal (glycopyrolate and neostigmine) and then 1,2,5,10,20,30 minutes ,1,2,4 and 6 hours after extubation. If values of blood pressure rise more than 20% from baseline values injection Metoprolol 1mg (beta blocker) bolus will be used and titrated according to response. The study will end at 6 hours post extubation.</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128.55" spread="21.56"/>
                    <measurement group_id="O2" value="132.34" spread="22.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1min Before Extubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="132.63" spread="22.12"/>
                    <measurement group_id="O2" value="134.29" spread="24.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1min After Extubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="141.81" spread="23.15"/>
                    <measurement group_id="O2" value="143.70" spread="22.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="134.89" spread="21.57"/>
                    <measurement group_id="O2" value="139.77" spread="22.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="130.05" spread="20.06"/>
                    <measurement group_id="O2" value="133.37" spread="21.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126.95" spread="17.26"/>
                    <measurement group_id="O2" value="131.59" spread="17.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127.86" spread="14.56"/>
                    <measurement group_id="O2" value="133.15" spread="15.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127.19" spread="16.29"/>
                    <measurement group_id="O2" value="132.10" spread="17.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128.11" spread="14.47"/>
                    <measurement group_id="O2" value="129.80" spread="16.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127.76" spread="16.21"/>
                    <measurement group_id="O2" value="125.74" spread="13.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127.35" spread="15.48"/>
                    <measurement group_id="O2" value="125.81" spread="12.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122.97" spread="14.18"/>
                    <measurement group_id="O2" value="122.61" spread="17.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Haemodynamic Parameters at the Time of Emergence and Postextubation</title>
        <description>Heart rate will be recorded at 1 minute before giving the reversal (glycopyrolate and neostigmine) and then 1,2,5,10,20,30 minutes ,1,2,4 and 6 hours after extubation. If haemodynamic values of heart rate rise more than 20% from baseline values injection Metoprolol 1mg (beta blocker) bolus will be used and titrated according to response. The study will end at 6 hours post extubation.</description>
        <time_frame>HR from the time of extubation till 6 hours post operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tramadol</title>
            <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg once at the time of dura closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
          </group>
        </group_list>
        <measure>
          <title>Haemodynamic Parameters at the Time of Emergence and Postextubation</title>
          <description>Heart rate will be recorded at 1 minute before giving the reversal (glycopyrolate and neostigmine) and then 1,2,5,10,20,30 minutes ,1,2,4 and 6 hours after extubation. If haemodynamic values of heart rate rise more than 20% from baseline values injection Metoprolol 1mg (beta blocker) bolus will be used and titrated according to response. The study will end at 6 hours post extubation.</description>
          <units>bpm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.26" spread="12.77"/>
                    <measurement group_id="O2" value="79.37" spread="16.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1min Before Extubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.30" spread="14.50"/>
                    <measurement group_id="O2" value="91.41" spread="16.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1min After Extubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.61" spread="15.39"/>
                    <measurement group_id="O2" value="98.54" spread="19.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.61" spread="16.71"/>
                    <measurement group_id="O2" value="93.50" spread="17.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.27" spread="15.77"/>
                    <measurement group_id="O2" value="90.00" spread="17.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.26" spread="16.59"/>
                    <measurement group_id="O2" value="86.70" spread="16.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.44" spread="16.18"/>
                    <measurement group_id="O2" value="83.38" spread="15.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.92" spread="14.19"/>
                    <measurement group_id="O2" value="84.10" spread="14.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.53" spread="13.34"/>
                    <measurement group_id="O2" value="82.46" spread="13.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.03" spread="13.40"/>
                    <measurement group_id="O2" value="81.97" spread="14.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.94" spread="13.20"/>
                    <measurement group_id="O2" value="81.23" spread="16.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.65" spread="11.78"/>
                    <measurement group_id="O2" value="78.20" spread="15.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Haemodynamic Parameters at the Time of Emergence and Postextubation</title>
        <description>Diastolic blood pressure will be recorded at 1 minute before giving the reversal (glycopyrolate and neostigmine) and then 1,2,5,10,20,30 minutes ,1,2,4 and 6 hours after extubation. If values of blood pressure rise more than 20% from baseline values injection Metoprolol 1mg (beta blocker) bolus will be used and titrated according to response. The study will end at 6 hours post extubation.</description>
        <time_frame>Diastolic BP from the time of extubation till 6 hours post operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tramadol</title>
            <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg once at the time of dura closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
          </group>
        </group_list>
        <measure>
          <title>Haemodynamic Parameters at the Time of Emergence and Postextubation</title>
          <description>Diastolic blood pressure will be recorded at 1 minute before giving the reversal (glycopyrolate and neostigmine) and then 1,2,5,10,20,30 minutes ,1,2,4 and 6 hours after extubation. If values of blood pressure rise more than 20% from baseline values injection Metoprolol 1mg (beta blocker) bolus will be used and titrated according to response. The study will end at 6 hours post extubation.</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Base line</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.92" spread="11.48"/>
                    <measurement group_id="O2" value="77.83" spread="12.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1min Before Extubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.30" spread="11.96"/>
                    <measurement group_id="O2" value="78.65" spread="12.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1min After Extubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.97" spread="10.69"/>
                    <measurement group_id="O2" value="85.78" spread="13.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.19" spread="10.79"/>
                    <measurement group_id="O2" value="82.41" spread="12.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.68" spread="10.63"/>
                    <measurement group_id="O2" value="78.59" spread="10.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.37" spread="10.26"/>
                    <measurement group_id="O2" value="78.32" spread="8.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.19" spread="9.54"/>
                    <measurement group_id="O2" value="76.73" spread="9.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30min</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.14" spread="9.67"/>
                    <measurement group_id="O2" value="76.93" spread="9.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.39" spread="8.90"/>
                    <measurement group_id="O2" value="75.33" spread="8.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.71" spread="11.07"/>
                    <measurement group_id="O2" value="75.89" spread="8.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.85" spread="9.96"/>
                    <measurement group_id="O2" value="78.00" spread="11.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.26" spread="12.54"/>
                    <measurement group_id="O2" value="74.89" spread="11.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Measure the Quality of Emergence From General Anaesthesia by Measuring the Frequency of Cough on Cough Scale.</title>
        <description>Cough will be described on following scale 5 = No coughing or straining, 4 = Very smooth minimal coughing, 3 = Moderate coughing, 2 = Marked coughing or straining,&#xD;
1 = Poor extubation&#xD;
Cough will be recorded on the above mentioned scale by resident/consultant at following time intervals of emergence&#xD;
At resumption of spontaneous breathing,&#xD;
Ability to respond to verbal commands&#xD;
At cuff deflation&#xD;
At extubation&#xD;
2 minutes after extubation. It will be noted if it occurs during emergence at the above mentioned time intervals. Absence of it will be considered as smooth emergence.</description>
        <time_frame>Cough at the time of emergence</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tramadol</title>
            <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg once at the time of dura closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
          </group>
        </group_list>
        <measure>
          <title>Measure the Quality of Emergence From General Anaesthesia by Measuring the Frequency of Cough on Cough Scale.</title>
          <description>Cough will be described on following scale 5 = No coughing or straining, 4 = Very smooth minimal coughing, 3 = Moderate coughing, 2 = Marked coughing or straining,&#xD;
1 = Poor extubation&#xD;
Cough will be recorded on the above mentioned scale by resident/consultant at following time intervals of emergence&#xD;
At resumption of spontaneous breathing,&#xD;
Ability to respond to verbal commands&#xD;
At cuff deflation&#xD;
At extubation&#xD;
2 minutes after extubation. It will be noted if it occurs during emergence at the above mentioned time intervals. Absence of it will be considered as smooth emergence.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At resumption of spontaneous breathing</title>
              <category_list>
                <category>
                  <title>Poor extubation</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Marked coughing or straining</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate coughing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very smooth minimal coughing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No coughing or straining</title>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ability to respond to verbal commands</title>
              <category_list>
                <category>
                  <title>Poor extubation</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Marked coughing or straining</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate coughing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very smooth minimal coughing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No coughing or straining</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At cuff deflation</title>
              <category_list>
                <category>
                  <title>Poor extubation</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Marked coughing or straining</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate coughing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very smooth minimal coughing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No coughing or straining</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At extubation</title>
              <category_list>
                <category>
                  <title>Poor extubation</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Marked coughing or straining</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate coughing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very smooth minimal coughing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No coughing or straining</title>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 minutes after extubation</title>
              <category_list>
                <category>
                  <title>Poor extubation</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Marked coughing or straining</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate coughing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very smooth minimal coughing</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No coughing or straining</title>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Measure the Quality of Emergence From General Anaesthesia by Measuring the Frequency of Laryngospasm and Bronchospasm.</title>
        <description>If there is any episode of bronchospasm or laryngospasm, it will be noted if it occured during emergence and for 6 hours post operatively. Absence of it will be considered as smooth emergence</description>
        <time_frame>at the time of extubation till 6 hours postoperatively</time_frame>
        <population>Laryngospasm and Bronchospasm and breath holding did not occur, therefore not shown there.</population>
        <group_list>
          <group group_id="O1">
            <title>Tramadol</title>
            <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg once at the time of dura closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
          </group>
        </group_list>
        <measure>
          <title>Measure the Quality of Emergence From General Anaesthesia by Measuring the Frequency of Laryngospasm and Bronchospasm.</title>
          <description>If there is any episode of bronchospasm or laryngospasm, it will be noted if it occured during emergence and for 6 hours post operatively. Absence of it will be considered as smooth emergence</description>
          <population>Laryngospasm and Bronchospasm and breath holding did not occur, therefore not shown there.</population>
          <units>Number of Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Measure the Quality of Emergence From General Anaesthesia by Measuring Sedation Score</title>
        <description>If there is any episode of sedation it will be noted if it occurs during emergence and for 6 hours post operatively. Absence of it will be considered as smooth emergence.&#xD;
sedation score will be used as 0= no sedation, 1= mildly sedated (eye opening on verbal commands), 2= moderately sedated ( awakens on giving pain), 3= deeply sedated ( not waking up even on pain)</description>
        <time_frame>at the time of extubation till 6 hours postoperatively</time_frame>
        <population>The data was inconsistent and was not reported adequately in the questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>Tramadol</title>
            <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg once at the time of dura closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
          </group>
        </group_list>
        <measure>
          <title>Measure the Quality of Emergence From General Anaesthesia by Measuring Sedation Score</title>
          <description>If there is any episode of sedation it will be noted if it occurs during emergence and for 6 hours post operatively. Absence of it will be considered as smooth emergence.&#xD;
sedation score will be used as 0= no sedation, 1= mildly sedated (eye opening on verbal commands), 2= moderately sedated ( awakens on giving pain), 3= deeply sedated ( not waking up even on pain)</description>
          <population>The data was inconsistent and was not reported adequately in the questionnaire.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Effect of Tramadol on Quality of Emergence Measured by Extubation Response Through Monitoring PONV</title>
        <description>Post operative nausea vomiting will be recorded at RR, 2, 4 and 6 hours postoperatively. If there is any episode of PONV it will be noted. Absence of it will be considered as smooth emergence</description>
        <time_frame>at Recovery Room , 2, 4 and 6 hours postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tramadol</title>
            <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg once at the time of dura closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Tramadol on Quality of Emergence Measured by Extubation Response Through Monitoring PONV</title>
          <description>Post operative nausea vomiting will be recorded at RR, 2, 4 and 6 hours postoperatively. If there is any episode of PONV it will be noted. Absence of it will be considered as smooth emergence</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Recovery Room</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Effect of Tramadol on Quality of Emergence Measured by Extubation Response Through Monitoring Convulsions</title>
        <description>Convulsions will be recorded at Recovery Room, 2, 4 and 6 hours postoperatively.If there is any episode of convulsion, it will be noted. Absence of it will be considered as smooth emergence.</description>
        <time_frame>at Recovery Room, 2, 4 and 6 hours postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tramadol</title>
            <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg once at the time of dura closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Tramadol on Quality of Emergence Measured by Extubation Response Through Monitoring Convulsions</title>
          <description>Convulsions will be recorded at Recovery Room, 2, 4 and 6 hours postoperatively.If there is any episode of convulsion, it will be noted. Absence of it will be considered as smooth emergence.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Recovery Room</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Effect of Tramadol on Quality of Emergence Measured by Extubation Response Through Monitoring GCS</title>
        <description>Post operative Glasgow Coma Scale (GCS) will be recorded at Recovery Room, 2, 4 and 6 hours postoperatively. If there is any deterioration in GCS less than 8/15, Patients will be intubated.&#xD;
GCS categories &lt;8 Low GCS 9-12 Intermediate GCS 13-15 Full GCS</description>
        <time_frame>at Recovery Room, 2, 4 and 6 hours postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tramadol</title>
            <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg once at the time of dura closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Tramadol on Quality of Emergence Measured by Extubation Response Through Monitoring GCS</title>
          <description>Post operative Glasgow Coma Scale (GCS) will be recorded at Recovery Room, 2, 4 and 6 hours postoperatively. If there is any deterioration in GCS less than 8/15, Patients will be intubated.&#xD;
GCS categories &lt;8 Low GCS 9-12 Intermediate GCS 13-15 Full GCS</description>
          <units>Number of Patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Recovery Room : &lt;8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Recovery Room : 9-12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Recovery Room : 13-15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2h : &lt;8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2h : 9-12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2h : 13-15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4h : &lt;8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4h : 9-12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4h : 13-15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6h : &lt;8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6h : 9-12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6h : 13-15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Effect of Tramadol on Quality of Emergence Measured by Extubation Response Through Mointoring Requirement of Analgesia</title>
        <description>Requirement of analgesia will be recorded at recovery room, 2, 4 and 6 hours postoperatively. If there is any need of analgesic, it will be noted and will be considered as one of the determinants of poor quality of emergence.</description>
        <time_frame>At Recovery room, 2, 4 and 6 hours postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tramadol</title>
            <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg once at the time of dura closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
          </group>
        </group_list>
        <measure>
          <title>Effect of Tramadol on Quality of Emergence Measured by Extubation Response Through Mointoring Requirement of Analgesia</title>
          <description>Requirement of analgesia will be recorded at recovery room, 2, 4 and 6 hours postoperatively. If there is any need of analgesic, it will be noted and will be considered as one of the determinants of poor quality of emergence.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Recovery Room</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Measure the Quality of Emergence From General Anaesthesia by Measuring the Frequency of Episodes of Denaturation</title>
        <description>If there is any episodes of denaturation (Oxygen saturation &lt;92%), it will be noted it it is occurring during emergence.&#xD;
Absence of it will be considered as smooth emergence</description>
        <time_frame>at the time of extubation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tramadol</title>
            <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg once at the time of dura closure</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
          </group>
        </group_list>
        <measure>
          <title>Measure the Quality of Emergence From General Anaesthesia by Measuring the Frequency of Episodes of Denaturation</title>
          <description>If there is any episodes of denaturation (Oxygen saturation &lt;92%), it will be noted it it is occurring during emergence.&#xD;
Absence of it will be considered as smooth emergence</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="38"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>at resumption of spontaneous breathing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at the time of obeying of verbal commands</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at the time of cuff deflation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>at the time of extubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 min after extubation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Event occured in the immediate postoperative period</time_frame>
      <desc>Patient had low GCS of 8 in recovery room, and got reintubated within 2 hours of extubation, post craniotomy. After treatment with desmopressin for Diabetes insipidus patient recovered and was extubated in ICU within 48 hours.</desc>
      <group_list>
        <group group_id="E1">
          <title>Tramadol</title>
          <description>Injection Tramadol 100mg diluted in 10 cc syringe (10mg/ml) to be given as 1mg/kg once at the time of dura closure</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>0.9% Normal saline in 10 cc syringe,1ml/10kg via intravenous route, once at the time of dura closure</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>Placebo</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>low conscious levels in post operative period</sub_title>
                <description>One patient had a GCS of 8 after extubation and was shifted to ICU after getting reintubated. Reason was diabetes insipidus which was treated with Desmopressin.GCS improved later and the patient was extubated in 48 hours</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Asma Abdus Salam</name_or_title>
      <organization>Aga Khan University</organization>
      <phone>+92-21-34864715 ext 4639</phone>
      <email>asma.salam.azhar@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

